- Home
- TAK vs ARES Comparison
TAK vs ARES Comparison
Compare TAK & ARES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- ARES
- Stock Information
- Founded
- TAK 1781
- ARES 1997
- Country
- TAK Japan
- ARES United States
- Employees
- TAK N/A
- ARES N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- ARES Investment Managers
- Sector
- TAK Health Care
- ARES Finance
- Exchange
- TAK Nasdaq
- ARES Nasdaq
- Market Cap
- TAK 42.5B
- ARES 35.1B
- IPO Year
- TAK N/A
- ARES 2014
- Fundamental
- Price
- TAK $13.32
- ARES $177.64
- Analyst Decision
- TAK
- ARES Buy
- Analyst Count
- TAK 0
- ARES 14
- Target Price
- TAK N/A
- ARES $166.77
- AVG Volume (30 Days)
- TAK 1.8M
- ARES 1.1M
- Earning Date
- TAK 01-30-2025
- ARES 02-06-2025
- Dividend Yield
- TAK 4.74%
- ARES 2.09%
- EPS Growth
- TAK 49.73
- ARES 0.39
- EPS
- TAK 1.27
- ARES 2.19
- Revenue
- TAK $31,732,209,416.00
- ARES $3,679,765,000.00
- Revenue This Year
- TAK $4.41
- ARES $0.31
- Revenue Next Year
- TAK $1.09
- ARES $33.19
- P/E Ratio
- TAK $20.89
- ARES $81.47
- Revenue Growth
- TAK 9.43
- ARES 4.67
- 52 Week Low
- TAK $12.58
- ARES $112.83
- 52 Week High
- TAK $15.08
- ARES $185.06
- Technical
- Relative Strength Index (RSI)
- TAK 40.07
- ARES 53.91
- Support Level
- TAK $13.26
- ARES $174.48
- Resistance Level
- TAK $13.42
- ARES $185.06
- Average True Range (ATR)
- TAK 0.14
- ARES 3.43
- MACD
- TAK -0.02
- ARES -0.19
- Stochastic Oscillator
- TAK 7.95
- ARES 34.19
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About ARES Ares Management Corporation
Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets and Secondaries Group. Its Credit Group generates maximum revenue, and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate and infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure and credit.